Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MRI Repair Measures in Alemtuzumab-Treated RRMS
NCT01307332Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Mar 2011
- Primary completion
- Sep 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of alemtuzumab in multiple sclerosis (MS), sponsored by University of British Columbia. Started Mar 2011; status: completed.
02
Drugs
alemtuzumab
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NCT01307332.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01307332.